Login to Your Account

F-star Gets $11.5M to Bolster Antibody Engineering Platform

By Cormac Sheridan

Wednesday, January 6, 2010
F-star Biotechnologische Forschungs-und Entwicklungsges mbH added another €8 million (US$11.5 million) in a third closing of a Series A round that had previously yielded €9 million, spread across two tranches. (BioWorld International)

To continue reading subscribe now to BioWorld Asia (formerly International)

Learn More about BioWorld Asia (formerly International)

Already a subscriber? Sign In or Buy now to activate your subscription